Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Qinghai Gelatin to Sell TCM Subsidiary to Chongqing Lummy Pharma

publication date: Dec 9, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Qinghai Gelatin has reached a framework agreement to sell its drug making subsidiary, Sichuan Hezheng Pharmaceutical, to Chongqing Lummy Pharmaceutical for 90 million RMB ($13.5 million). Hezheng Pharma produces TCM products in the form of pills, granules, capsules, tablets, and non-food health products.  More details....

Stock Symbols: (SHEX: 000606) (SHEX: 300006)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...



ChinaBio® Events
Shanghai, China
April 15-16, 2015

>> More events...

Partner Events

China Healthcare Investment Conference
March 31 – April 2, 2015
Shanghai, China

Asia Biotech Invest 2015
May19-21, 2015
Hong Kong, China
>> More events...
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors